tiprankstipranks
Bellicum Pharmaceuticals (BLCM)
OTHER OTC:BLCM

Bellicum Pharmaceuticals (BLCM) Stock Investors

707 Followers
Based on 718,776 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BLCM
On average, investors allocate 0.00% of their portfolios to BLCM
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BLCM

1.1%
Last 7
Days
4.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BLCM, out of 718,776 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BLCM Investor Activity

No data currently available
Based on the activity of 13,442 investors who made their portfolios public
The table shows changes in BLCM in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BLCM Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.60%
-1.02%
-3.98%
252.80M
Healthcare
Assertio Therapeutics
2.63%
-1.05%
-4.10%
83.54M
Healthcare
Micron
5.37%
+2.04%
+6.78%
105.72B
Technology
DraftKings
7.23%
-0.03%
+5.67%
38.89B
Consumer Cyclical
AbbVie
5.88%
-0.34%
+1.42%
312.75B
Healthcare
AMC Entertainment
5.42%
-0.41%
-2.59%
1.14B
Communication Services
Merck & Company
4.12%
+0.05%
+2.95%
314.17B
Healthcare
Cisco Systems
4.57%
+0.30%
+2.49%
198.94B
Technology
Boeing
6.03%
-0.10%
+2.15%
122.36B
Industrials
Tilray
3.71%
-0.93%
-3.19%
1.26B
Healthcare
Based on the activity of 718,776 active portfolios
Open your Smart Portfolio

BLCM Investor Analysis

BLCM investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.8%
of BLCM holders
are under 35
Average Segment Performance
Average P/E Ratio43.88
Beta7.32
Dividend Yield5.62%
BLCM investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
46.3%
of BLCM holders
are between 35–55
Average Segment Performance
Average P/E Ratio47.96
Beta11.09
Dividend Yield6.73%
BLCM investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
43.9%
of BLCM holders
are over 55
Average Segment Performance
Average P/E Ratio35.58
Beta5.76
Dividend Yield5.55%
Overview of age group and performance of BLCM stock investors
See who invests in BLCM according to age group and performance.

FAQ

How many retail Investors hold BLCM?
<0.1% of TipRanks' retail investors hold BLCM in their portfolios.
    What is BLCM Investor Sentiment?
    BLCM’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of BLCM in the last 7 days?
      ▼ 1.1% of TipRanks' retail investors changed their holding of BLCM in the last 7 days.
        What percentage of retail investors changed their holding of BLCM in the last 30 days?
        ▼ 4.2% of TipRanks' retail investors changed their holding of BLCM in the last 30 days.
          What is the average age of retail investors who hold BLCM?
          The average age of BLCM Holders is between 35–55.
            What other stocks have BLCM investors also bought?
            BLCM Investors also bought CHRS, ASRT, MU, DKNG, ABBV, AMC, MRK, CSCO, BA, TLRY.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              CORCencora
              BDXBecton Dickinson
              CAHCardinal Health
              CNCCentene
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis